2023, FDA and Vaccines - Pharmacy Technician Pulse

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Drug Topics

JULY 11, 2025

In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. The study cohort included 6.8

Vaccines

Vaccines Immunization Specialty Pharmacies Compounding

Pharmacist, Provider Partnership Can Help Increase RSV Vaccine Uptake

Drug Topics

AUGUST 12, 2025

Partnerships between community pharmacists and local primary care providers can help increase the uptake of respiratory syncytial virus (RSV) vaccines, according to recent data published in the journal JAPhA Practice Innovations. Prevention of the disease was previously limited to palivizumab, a costly antibody. had comorbidities.

Vaccines

Vaccines Health and Personal Care Stores Specialty Pharmacies Community Pharmacies

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings. ACIP's recommendations are increasingly significant for pharmacies, influencing vaccination planning, billing, and patient care activities.

Vaccines

Vaccines Community Pharmacies Immunization Compounding Pharmacies

V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults

Pharmacy Times

AUGUST 12, 2025

The vaccine showed superior immune response for unique serotypes compared to PPSV23, with higher OPA titers. Insights from the Japanese study can inform global pneumococcal vaccination strategies for older adults at increased risk. 1 Older adults are at increased risk of invasive pneumococcal disease.

Immunization

Immunization Vaccines Compounding Pharmacies FDA

From Pharmacy Counters to Classrooms: Building Confidence in Back-to-School Vaccinations

Pharmacy Times

AUGUST 6, 2025

Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates. Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates.

Vaccines

Vaccines Immunization Compounding Pharmacies Hospitals

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period.

Vaccines

Vaccines Compounding Pharmacies Immunization Hospitals

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Pharmacy Times

JULY 25, 2025

Increased awareness of infectious diseases during the pandemic may have improved vaccine uptake among Medicare enrollees, while service reductions and vaccine hesitancy affected Medicaid enrollees.

Vaccines

Vaccines Compounding Pharmacies Immunization Compounding

Updated COVID-19 mRNA Vaccine Did Not Increase Risk for Adverse Events

Drug Topics

JULY 29, 2025

The updated COVID-19 mRNA vaccine that contained the Omicron JN.1 The updated COVID-19 mRNA vaccine that contained the Omicron JN.1 Investigators analyzed 29 AEs of special interest for COVID-19 vaccinations. 1 The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 1 booster vaccination. .

Vaccines

Vaccines Specialty Pharmacies Independent Pharmacies Immunization

Pharmacists Can Simplify the Vaccine Schedule

Pharmacy Times

JULY 22, 2025

RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available. RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available.

Vaccines

Vaccines Immunization Compounding Pharmacies FDA

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

JUNE 24, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Compounding Pharmacies Immunization Mayo Clinic Hospitals

Shaping Pharmacy Research With Purpose and Public Impact

Pharmacy Times

JULY 22, 2025

Finerenone and the Future of Diabetes-Related Kidney Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Compounding Pharmacies

Compounding Pharmacies Compounding Immunization Hospitals

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

JULY 16, 2025

14,15 Lung Cancer Tarlatamab Significantly Improves Survival in Patients With Small Cell Lung Cancer Post Progression Tarlatamab has shown promising efficacy in relapsed SCLC based on the initial single-arm trial findings, leading to an FDA approval in 2024, but challenges with administration have limited its widespread adoption.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization Chemotherapy

Flu Fighters: Pharmacists Partnering to Protect Communities

Pharmacy Times

AUGUST 5, 2025

Building trust and relationships with community partners is essential for effective vaccine advocacy and outreach. Offering education, mobile clinics, and convenient access to vaccines can address barriers and improve vaccination rates. Community pharmacists are among the most accessible and trusted health care professionals.

Vaccines

Vaccines Compounding Pharmacies Grocery Stores Immunization

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Pharmacy Times

JULY 2, 2025

The FDA has approved vancomycin injection, USP (Tyzavan; Hikma Pharmaceuticals PLC), for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections in adult and pediatric patients 1 month and older for whom appropriate dosing can be achieved.

FDA

FDA Compounding Pharmacies Hospitals Compounding

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

Pharmacy Times

JULY 14, 2025

Topics included innovative clinical services , vaccine access , and the interaction of pharmacology and nutrition. PharmaTalk sessions—dynamic conversations between pharmacy experts—featured thought leaders and pharmacy innovators sharing insights on the evolving health care landscape.

Independent Pharmacies

Independent Pharmacies Compounding Pharmacies Patient Care Hospitals

Pharmacists Improve Infectious Disease Outcomes, Reduce Costs

Drug Topics

AUGUST 8, 2025

November 21, 2023. Impact of pharmacist-led anti-infective consultations on therapeutic outcomes: a retrospective cohort study in a tertiary hospital. Infect Drug Resist. 2025 Jul 28;18:3735-3744. doi: 10.2147/IDR.S534678. Antimicrobial resistance. Accessed August 8, 2025. Antimicrobial resistance facts and stats. February 4, 2025.

Specialty Pharmacies

Specialty Pharmacies FDA Vaccines Compounding

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Pharmacy Times

AUGUST 7, 2025

SHOW MORE The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management practices. Pharmacists are pivotal in educating patients, verifying prescriptions, and collaborating with prescribers to ensure safe opioid management and reduce harm.

Labelling

Labelling FDA Compounding Pharmacies Immunization

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Pharmacy Times

JULY 22, 2025

Historically, the FDA has required preclinical testing in animals to obtain safety and efficacy data for investigational new drugs (INDs) before they can begin clinical testing in humans. 3 More simply, the FDA is moving preclinical testing from in vivo animal models to in silico and in vitro methods.

FDA

FDA Compounding Immunization Compounding Pharmacies

Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.

Pharmacy Times

AUGUST 1, 2025

In 2023, the Texas Legislature passed HB 1919 and HB 1764, legislation that prohibits PBMs from steering patients toward PBM-owned pharmacies, charging retroactive fees, or unfairly reimbursing their own pharmacies at higher rates than what they pay local, independent ones. Texas also stands out as a leader in the fight for PBM reform.

Specialty Pharmacies

Specialty Pharmacies Independent Pharmacies Mail-Order Pharmacies Compounding Pharmacies

Pharmacists Bridge the Gaps in Care Transitions

Pharmacy Times

AUGUST 11, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Hospitals

Hospitals Community Pharmacies Specialty Pharmacies Compounding Pharmacies

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Pharmacy Times

JUNE 20, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Specialty Pharmacies

Moving the Needle From Vaccine Hesitancy to Vaccine Acceptance

Pharmacy Times

JULY 28, 2025

Grillo, MBA, RPh Key Takeaways Vaccination has saved millions of lives, yet vaccine hesitancy remains a significant global health threat, fueled by misinformation and systemic barriers. SHOW MORE Many factors contribute to vaccine skepticism, including trust, convenience, and fear. million premature deaths.

Vaccines

Vaccines Immunization Compounding Pharmacies Hospitals

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

JULY 22, 2025

These deserts reduce access to critical health care services, such as vaccinations, health screenings, and point-of-care testing. The lack of access to immunization services may lead to lower vaccination rates and vulnerabilities to infectious diseases in these communities.

Mail-Order Pharmacies

Mail-Order Pharmacies Community Pharmacies Compounding Pharmacies Immunization

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

JUNE 27, 2025

SHOW MORE The FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma. The phase 3 ECHO trial showed significant progression-free survival improvement with acalabrutinib, supporting its approval as a new standard of care for untreated MCL.

FDA

FDA Compounding Pharmacies Immunization Chemotherapy

Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression

Pharmacy Times

AUGUST 8, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Hospitals Immunization

Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Chemotherapy

Chemotherapy Compounding Pharmacies Immunization Hospitals

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacy Times

JULY 21, 2025

Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. Targeted public health strategies are needed to improve vaccine access, education, and trust, particularly in underserved communities.

Vaccines

Vaccines Immunization Hospitals Compounding Pharmacies

3 of the year’s most notable FDA nods

PharmaVoice

JUNE 27, 2025

Despite worried hand-wringing over a potential slowdown in FDA approvals under the new administration, the agency has been giving the go-ahead to drugs at a near record-setting clip. Meanwhile, the decision-making production has come during a major upheaval inside the FDA. Please let us know if you have feedback.

FDA

FDA Vaccines Packaging Dosage

Zongertinib Approved by FDA for Patients With Nonsquamous NSCLC With HER2 TKD Mutations

Pharmacy Times

AUGUST 8, 2025

The FDA's accelerated approval of zongertinib marks a significant advancement for patients with HER2-mutated NSCLC, offering a new treatment option.

FDA

FDA Compounding Pharmacies Hospitals Chemotherapy

Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025

Drug Topics

JUNE 23, 2025

McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare. McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.

Community Pharmacies

Community Pharmacies Specialty Pharmacies Compounding Independent Pharmacies

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

JUNE 24, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Compounding

Carefully Monitor Direct Oral Anticoagulant Medications

Pharmacy Times

JULY 26, 2025

Although some of these medications have additional FDA-approved uses (ie, rivaroxaban to reduce the risk of thrombotic vascular events in patients with peripheral artery disease), all 4 DOACs are approved for the treatment and prevention of venous thromboembolism and stroke prevention in nonvalvular atrial fibrillation (AFib). MedlinePlus.

Compounding Pharmacies

Compounding Pharmacies Vaccines Immunization Hospitals

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines

Vaccines Independent Pharmacies Immunization Compounding

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Pharmacy Times

JUNE 12, 2025

Data collection spanned January 2020 to March 2023. Related Videos Related Content Advertisement June 12th 2025 Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer Alexandra Gerlach, Associate Editor June 3rd 2025 S2.

Compounding Pharmacies

Compounding Pharmacies Immunization Vaccines Specialty Pharmacies

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Drug Topics

JULY 17, 2025

They then searched internet databases on November 19, 2023, to quantify the role of pharmacists’ interventions in COPD management. The researchers’ method for doing so consisted of the curation of key research questions: “What impact do pharmacist-led interventions have on health-related outcomes of patients with COPD?”

Specialty Pharmacies

Specialty Pharmacies Mayo Clinic Patient Care Hospitals

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Pharmacy Times

JUNE 9, 2025

Study Overview Researchers conducted a retrospective chart review of 80 patients aged 12 or older within Intermountain Health who were diagnosed with asthma between December 2022 and December 2023. To ensure continuity of care, patients included had seen a primary care provider both in the year prior to and following their diagnosis.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Chemotherapy

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Pharmacy Times

JUNE 16, 2025

Nemolizumab targets IL-31 receptor alpha, inhibiting itch and inflammation, and is FDA-approved for use with topical therapies in patients 12 and older. Nemolizumab also received FDA approval in August 2024 as a pre-filled pen for subcutaneous injection for the treatment of adults with prurigo nodularis.

Compounding Pharmacies

Compounding Pharmacies FDA Immunization Mayo Clinic

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

Pharmacy Times

JUNE 11, 2025

Related Videos Related Content Advertisement June 11th 2025 Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV Kennedy Ferruggia, Assistant Editor June 3rd 2025 S2. Subscribe Now!

Specialty Pharmacies

Specialty Pharmacies Hospitals Compounding Pharmacies FDA

Pharmacists Can Educate Patients About Sun Safety

Pharmacy Times

JULY 24, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Compounding Pharmacies Community Pharmacies Vaccines Immunization

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Pharmacy Times

JULY 21, 2025

Transformative advances in continuous glucose monitoring and the impact of FDA over-thecounter approval on diabetes care. As accessible health care providers, pharmacists can educate patients on how to best use these devices, empowering them to take charge of their own health care. REFERENCES Afridi Z, Rauf SA, Ashraf SMN, Haque MA.

Compounding Pharmacies

Compounding Pharmacies Immunization Insurance Coverage Hospitals

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

Pharmacy Times

JUNE 13, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Vaccines

Self-Care Measures for Preventing and Managing Dysmenorrhea

Pharmacy Times

JUNE 20, 2025

November 6, 2023. J Pediatr Adolesc Gynecol. 2014;27(5):258-265.doi:10.1016/j.jpag.2013.11.008 doi:10.1016/j.jpag.2013.11.008 2013.11.008 7. Menstrual cycle disorders may be linked to increased cardiovascular disease risk in women. News release. American Heart Association. Accessed April 28, 2025. Pinkerton JV. Dysmenorrhea. In: Merck Manual.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Compounding

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacy Times

JUNE 4, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Compounding Pharmacies Compounding Immunization Specialty Pharmacies

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacy Times

JUNE 23, 2025

The retrospective cohort study included all patients who met the criteria for the Medicare HRRP COPD model discharged between May 2021 and August 2023. The researchers included 187 patients and 92 patients in the pre- and postimplementation groups, respectively.

Hospitals

Hospitals Compounding Pharmacies Vaccines Immunization

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Pharmacist, Provider Partnership Can Help Increase RSV Vaccine Uptake

Trending Sources

Flu Vaccines Are a Go

V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults

From Pharmacy Counters to Classrooms: Building Confidence in Back-to-School Vaccinations

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Updated COVID-19 mRNA Vaccine Did Not Increase Risk for Adverse Events

Pharmacists Can Simplify the Vaccine Schedule

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Shaping Pharmacy Research With Purpose and Public Impact

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Flu Fighters: Pharmacists Partnering to Protect Communities

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

Pharmacists Improve Infectious Disease Outcomes, Reduce Costs

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.

Pharmacists Bridge the Gaps in Care Transitions

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Moving the Needle From Vaccine Hesitancy to Vaccine Acceptance

The Changing Landscape of Pharmacy Accessibility

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression

Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

3 of the year’s most notable FDA nods

Zongertinib Approved by FDA for Patients With Nonsquamous NSCLC With HER2 TKD Mutations

Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Carefully Monitor Direct Oral Anticoagulant Medications

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

Pharmacists Can Educate Patients About Sun Safety

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

Self-Care Measures for Preventing and Managing Dysmenorrhea

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Stay Connected